The Oncology Institute, Inc. (TOI) Misses Q3 EPS by 3c ; Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
Tweet
Share
E-mailGet Alerts TOI Hot Sheet
Join SI Premium – FREE
The Oncology Institute, Inc. (NASDAQ: TOI) reported Q3 EPS of ($0.14), $0.03 worse than the analyst estimate of ($0.11). Revenue for the quarter came in at $136.6 million versus the consensus estimate of $122.83 million.
Guidance 2025 :-
Revenue between $495 million to $505 million vs consensus $500.6 million.
For earnings history and earnings-related data on The Oncology Institute, Inc. (TOI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Pharming Group N.V. (PHAR) Reports Q3 results; offers guidance
- BMO Capital Upgrades IGM Financial Inc (IGM:CN) (IGIFF) to Outperform
- JPMorgan Downgrades Opmobility SE (OPM:FP) to Neutral
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
